Clinical Trial Update: Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement [Phase 2]

View source ↗

Summary

Phase 2 trial assessing SelK2 for safety and efficacy in preventing blood clots in patients undergoing total knee replacement has completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• SelK2 (SelK2)

Snippet

Sponsor: Tetherex Pharmaceuticals Corporation | Conditions: Venous Thromboembolism | Phase 2 | Status: COMPLETED | Results posted: 2020-11-24